Webinar Date/Time: Wed, Mar 6, 2024 10:00 AM EST
For anyone involved in packaging injectable drug products, understanding and addressing particulate matter is of utmost importance. Join us for a webinar that will delve deep into the world of particulate categorizations, considerations, and compendia, ensuring alignment with relevant regulatory bodies.
Register Free: https://www.pharmtech.com/pt_w/particulate-matters
Event Overview:
Particulate matter, as defined by the USP, refers to the presence of mobile undissolved particles in solutions, excluding gas bubbles. It is a critical aspect to consider for those involved in packaging injectable drug products, requiring a thorough understanding, mitigation, and adherence to regulatory standards. During this exclusive webinar, experts will delve into the fundamental aspects of categorizing, considering, and complying with particulate matter.
Key Learning Objectives:
Who Should Attend:
Speaker:
Gabrielle Gehron
Technical & Scientific Expert
Datwyler
Gabrielle Gehron attended college at Widener University. In that time, she earned both a Bachelor’s and Master’s degree in Biomedical Engineering, graduating with honors. In May of 2019, she entered the pharmaceutical packaging industry in a technical, customer-facing role, recommending and evaluating packaging components for major drug companies.
Since then, Gabrielle has worked in multiple customer-facing technical roles at two of the leading pharmaceutical packaging companies in the world. Through COVID-19 and the aftermath, she has supported major biologics, generics, and pharma companies to provide high-quality products to their patients. Gabrielle currently serves as a Technical and Scientific Expert on Datwyler's Technical and Scientific Support team.
Register Free: https://www.pharmtech.com/pt_w/particulate-matters
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.